tiprankstipranks
Trending News
More News >
Bunge Global (BG)
NYSE:BG

Bunge Global (BG) AI Stock Analysis

Compare
1,442 Followers

Top Page

BG

Bunge Global

(NYSE:BG)

Rating:64Neutral
Price Target:
$83.00
▲(1.95%Upside)
Bunge Global's overall score reflects strong financial stability and strategic initiatives, offset by challenges in cash flow, revenue decline, and regulatory uncertainties. The low valuation and high dividend yield offer some appeal, while technical indicators suggest cautious optimism.
Positive Factors
Earnings Outlook
Favorable RVO outcome should restore greater visibility to BG's earnings outlook.
Guidance
Guidance reaffirmed; RVO potential game changer.
Negative Factors
Acquisition
Termination of CJ Selecta acquisition is disappointing given accretion profile.
EPS Performance
EPS upside lower quality and 40-45% profit decline across segments demonstrates operating environment challenges.

Bunge Global (BG) vs. SPDR S&P 500 ETF (SPY)

Bunge Global Business Overview & Revenue Model

Company DescriptionBunge Limited operates as an agribusiness and food company worldwide. It operates through four segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes, and sells agricultural commodities and commodity products, including oilseeds primarily soybeans, rapeseed, canola, and sunflower seeds, as well as grains primarily wheat and corn; and processes oilseeds into vegetable oils and protein meals. This segment offers its products for animal feed manufacturers, livestock producers, wheat and corn millers, and other oilseed processors, as well as third-party edible oil processing and biofuel companies; and for industrial and biodiesel production applications. The Refined and Specialty Oils segment sells packaged and bulk oils and fats that include cooking oils, shortenings, margarines, mayonnaise, and other products for baked goods companies, snack food producers, confectioners, restaurant chains, foodservice operators, infant nutrition companies, and other food manufacturers, as well as grocery chains, wholesalers, distributors, and other retailers. The Milling segment provides wheat flours and bakery mixes; corn milling products that comprise dry-milled corn meals and flours, wet-milled masa and flours, and flaking and brewer's grits, as well as soy-fortified corn meal, corn-soy blends, and other products; whole grain and fiber ingredients; quinoas and millets; die-cut pellets; and non-GMO products. The Sugar and Bioenergy segment produces sugar and ethanol; and generates electricity from burning sugarcane bagasse. Bunge Limited was founded in 1818 and is headquartered in St. Louis, Missouri.
How the Company Makes MoneyBunge Global makes money through several key revenue streams, primarily centered around its diverse operations in the agricultural sector. The company generates revenue from the processing and sale of oilseeds into vegetable oils and protein meals, which are sold to food manufacturers, animal feed producers, and the biodiesel industry. In addition, Bunge earns income from the trading and merchandising of grains and oilseeds, leveraging its extensive network of storage facilities, transport assets, and customer relationships. The sugar and bioenergy segment contributes to revenues through the production and sale of sugar, ethanol, and electricity. Bunge's food and ingredients division adds another layer of revenue by supplying a variety of packaged food products and food ingredients to retail and foodservice channels. Significant partnerships, such as joint ventures and strategic alliances with other agribusiness entities, enhance Bunge's market reach and operational efficiency, further contributing to its earnings.

Bunge Global Earnings Call Summary

Earnings Call Date:May 07, 2025
(Q1-2025)
|
% Change Since: 5.06%|
Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment Neutral
While Bunge demonstrated resilience and strategic alignment through divestitures and partnerships, the earnings call highlighted challenges such as declines in adjusted EBIT and EPS, regulatory delays, and biofuel policy uncertainties. The achievements in financial positioning and strategic initiatives were somewhat offset by these challenges.
Q1-2025 Updates
Positive Updates
Exceeding Expectations in Q1 2025
First quarter exceeded expectations, driven by pull forward of activities from Q2 into Q1, and shifts in trade dynamics. Adjusted EPS was $1.81 compared to $3.04 in the prior year.
Strategic Divestitures and Partnerships
Sale of European Margarines and Spreads business and North American corn milling business. Partnership with Repsol to incorporate intermediate novel crops in renewable fuels in Europe.
Strong Financial Position
Generated $392 million of adjusted funds from operations with $338 million of discretionary cash flow available. Adjusted leverage ratio at 0.6 times and liquidity with committed credit facilities of approximately $8.7 billion.
Resilient Business Model
Confidence in the strategic merits of the planned combination with Viterra and expected approval soon. Commitment to global supply chains and value creation for customers.
Negative Updates
Decline in Adjusted EBIT
Adjusted segment EBIT was $406 million compared to $719 million last year, indicating challenges in the processing segment, particularly in North America, Argentina, and European soft seeds.
Lower Adjusted EPS
Adjusted EPS decreased to $1.81 in the first quarter from $3.04 in the prior year, highlighting a more balanced global supply and demand environment.
Challenges in Regulatory Approvals
Regulatory approval delays for the Vitara transaction and termination of the definitive share purchase agreement with CJ Selecta.
Biofuel Policy Uncertainty
Refined & Specialty Oils results down, driven by a more balanced supply and demand environment and uncertainty in U.S. biofuel policies.
Company Guidance
During the Bunge Global SA First Quarter 2025 earnings call, the company reaffirmed its full-year 2025 adjusted EPS guidance of approximately $7.75, despite a dynamic market environment. The first quarter exceeded expectations, with reported EPS of $1.48 and adjusted EPS of $1.81, although lower than the prior year's $3.04. Adjusted segment EBIT was $406 million, a decrease from $719 million in the previous year. The call highlighted a strong performance in Brazil, Europe, and Asia soy crush value chains, offset by lower results in North America, Argentina, and European soft seeds. Bunge emphasized continued uncertainty in U.S. biofuel policies and regulatory changes, which influenced trade dynamics, but it expects a more balanced supply and demand environment going forward. The company also provided metrics on capital allocation, including $392 million of adjusted funds from operations in Q1, and emphasized its robust liquidity position with $8.7 billion in unused credit facilities.

Bunge Global Financial Statement Overview

Summary
Bunge Global demonstrates strong profitability metrics with healthy margins, but faces challenges with declining revenue and negative free cash flow. The balance sheet is stable, though increasing debt levels necessitate careful management.
Income Statement
75
Positive
Bunge Global's income statement shows a strong gross profit margin of 6.1% and a net profit margin of 2.1% for TTM (Trailing-Twelve-Months). The EBIT margin is at a healthy 3.1%, and the EBITDA margin is 4.6%. However, the company has experienced a decline in revenue, with a negative revenue growth rate of -3.3% compared to the previous year, indicating potential challenges in maintaining revenue levels.
Balance Sheet
70
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.72, suggesting moderate leverage. The return on equity (ROE) stands at 10.3%, indicating effective use of equity to generate profits. The equity ratio is 39.7%, showcasing a solid equity foundation. Despite these strengths, the company's debt levels have increased, which could pose risks if not managed carefully.
Cash Flow
50
Neutral
The cash flow analysis reveals a challenging situation with a negative free cash flow of -814 million in TTM (Trailing-Twelve-Months), down from a positive free cash flow the previous year. The operating cash flow to net income ratio is 0.58, indicating that the company is generating less cash relative to its net income. Additionally, the free cash flow to net income ratio is negative, highlighting concerns over cash generation capabilities.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
51.33B53.11B59.54B67.23B59.15B41.40B
Gross Profit
3.11B3.39B4.84B3.68B3.36B2.79B
EBIT
1.61B1.83B3.42B2.40B2.76B1.66B
EBITDA
2.38B2.46B4.02B2.88B3.23B2.11B
Net Income Common Stockholders
1.09B1.14B2.24B1.61B2.08B1.15B
Balance SheetCash, Cash Equivalents and Short-Term Investments
3.88B3.79B2.71B1.22B1.42B698.00M
Total Assets
26.66B24.90B25.37B24.58B23.82B23.66B
Total Debt
7.66B7.12B5.76B5.62B6.82B8.10B
Net Debt
4.42B3.81B3.15B4.52B5.92B7.75B
Total Liabilities
15.07B13.95B13.56B14.62B15.61B17.04B
Stockholders Equity
10.58B9.91B10.85B9.22B7.67B6.07B
Cash FlowFree Cash Flow
-814.00M524.00M2.19B-6.10B-3.29B-3.90B
Operating Cash Flow
636.00M1.90B3.31B-5.55B-2.89B-3.54B
Investing Cash Flow
-982.00M-1.11B-1.01B6.50B5.11B1.81B
Financing Cash Flow
643.00M-90.00M-856.00M-769.00M-1.63B1.76B

Bunge Global Technical Analysis

Technical Analysis Sentiment
Positive
Last Price81.41
Price Trends
50DMA
77.35
Positive
100DMA
75.19
Positive
200DMA
81.21
Positive
Market Momentum
MACD
-0.21
Negative
RSI
62.56
Neutral
STOCH
59.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BG, the sentiment is Positive. The current price of 81.41 is above the 20-day moving average (MA) of 77.69, above the 50-day MA of 77.35, and above the 200-day MA of 81.21, indicating a bullish trend. The MACD of -0.21 indicates Negative momentum. The RSI at 62.56 is Neutral, neither overbought nor oversold. The STOCH value of 59.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BG.

Bunge Global Risk Analysis

Bunge Global disclosed 41 risk factors in its most recent earnings report. Bunge Global reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Bunge Global Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
84
Outperform
$5.14B4.7648.27%14.34%60.00%259.01%
FDFDP
76
Outperform
$1.57B10.727.51%3.66%-0.64%
SFSFD
72
Outperform
$9.26B
12.74%
ADADM
71
Outperform
$24.98B18.546.03%3.92%-8.59%-50.72%
TSTSN
67
Neutral
$19.14B20.885.01%3.65%1.39%
BGBG
64
Neutral
$10.94B10.3210.36%3.44%-10.90%-36.54%
51
Neutral
$2.03B-1.27-21.09%3.98%2.91%-30.50%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BG
Bunge Global
81.41
-18.23
-18.30%
ADM
Archer Daniels Midland
52.00
-5.84
-10.10%
CALM
Cal-Maine Foods
96.38
41.78
76.52%
FDP
Fresh Del Monte Produce
32.82
11.81
56.21%
TSN
Tyson Foods
54.81
0.98
1.82%
SFD
Smithfield Foods
23.56
3.55
17.74%

Bunge Global Corporate Events

M&A TransactionsRegulatory Filings and Compliance
Bunge Global Amends Business Combination Agreement
Neutral
Jun 13, 2025

On June 13, 2025, Bunge, along with Glencore, CPPIB, and BCI, amended their Business Combination Agreement, setting the closing date for their transactions, including an acquisition, to July 2, 2025. The amendment also extended the outside date to July 3, 2025, and waived certain conditions for closing. Approvals were received from regulatory bodies in China and Mexico, satisfying antitrust and foreign investment laws, with the transactions expected to be completed on July 2, 2025.

The most recent analyst rating on (BG) stock is a Hold with a $85.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.

Private Placements and FinancingM&A Transactions
Bunge Global Extends Exchange Offers for Viterra Acquisition
Neutral
Jun 12, 2025

On June 12, 2025, Bunge Global SA announced that its subsidiary, Bunge Limited Finance Corp., extended the expiration date for its exchange offers and consent solicitations related to Viterra Finance B.V.’s notes. This extension is part of Bunge’s pending acquisition of Viterra, with the expiration date moved to July 3, 2025, to accommodate the completion of the business combination. The extension aims to facilitate the exchange of existing notes for new Bunge notes and cash, while also amending certain indentures to eliminate covenants and modify provisions. The move is expected to impact the liquidity of Viterra’s existing notes and reduce protections for remaining holders.

The most recent analyst rating on (BG) stock is a Buy with a $128.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.

Executive/Board ChangesM&A TransactionsShareholder MeetingsDividendsBusiness Operations and Strategy
Bunge Global Shareholders Approve Key Proposals at AGM
Positive
May 19, 2025

At the 2025 Annual General Meeting held on May 15, Bunge Global SA’s shareholders approved several key proposals, including the Swiss statutory financial statements for 2024, a cash dividend of $2.80 per share, and the discharge of board members from liability for 2024. Additionally, the meeting saw the election of new directors, including Linda Jojo, whose expertise in business technology and cybersecurity is expected to bolster Bunge’s innovation efforts. The shareholders also approved the appointments of additional directors contingent on the closing of the Viterra Limited acquisition, reflecting Bunge’s strategic moves to enhance its market position.

The most recent analyst rating on (BG) stock is a Buy with a $128.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.